$921.49
6.450.70%
At Close: -
$920.75
-0.74-0.08%
After Hours: 7:25 PM EDT
15 minutes delayed
Eli Lilly reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $3.92 | $2.70 | 45.2 % |
Mar 2024 | 2024-04-30 | $2.58 | $2.46 | 4.88 % |
Dec 2023 | 2024-02-06 | $2.49 | $2.19 | 13.7 % |
Sep 2023 | 2023-11-02 | $0.10 | $-0.15 | 166.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $11.30B | $9.95B | 13.6 % |
Mar 2024 | 2024-04-30 | $8.77B | $8.92B | -1.70 % |
Dec 2023 | 2024-02-06 | $9.35B | $8.93B | 4.74 % |
Sep 2023 | 2023-11-02 | $9.50B | $8.95B | 6.13 % |
Eli Lilly (LLY) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $3.92, which beat the estimate of $2.70.
The Actual Revenue was $11.3B, which beat the estimate of $9.9B.
Browse earnings estimates, EPS, and revenue on all stocks.